Related Experiment Video

Updated: Sep 5, 2026

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
09:45

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors

Published on: April 27, 2017

PRELIMINARY CLINICAL EXPERIENCES WITH AN IMIPRAMINE-METABOLITE, G 35020, DESMETHYL-IMIPRAMINE-DMI

E S Kristiansen

    Acta Psychiatrica Scandinavica
    |January 1, 1963
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    AMINOTRANSFERASESBLOOD PRESSUREDEPRESSIONELECTROCARDIOGRAPHYELECTROENCEPHALOGRAPHYGERIATRICSGLUTAMINASEHEMOGLOBINOMETRYIMIPRAMINELEUKOCYTE COUNTPYRUVATESTOXICOLOGIC REPORTURINE

    More Related Videos

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease16:57

    MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

    Published on: February 14, 2012

    Related Concept Videos

    Depolarizing Blockers: Pharmocokinetics01:19

    Depolarizing Blockers: Pharmocokinetics

    Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...